/wp-content/uploads/peptilogics_inline_ko_rgb_72-300x79.png00David Anderson/wp-content/uploads/peptilogics_inline_ko_rgb_72-300x79.pngDavid Anderson2022-03-22 08:00:412022-04-27 12:48:45Peptilogics’ Presentations at American Academy of Orthopedic Surgeons (AAOS) 2022 Annual Meeting Highlight Peptide Therapeutic PLG0206 for the Treatment of Periprosthetic Joint Infection (PJI)
/wp-content/uploads/peptilogics_inline_ko_rgb_72-300x79.png00David Anderson/wp-content/uploads/peptilogics_inline_ko_rgb_72-300x79.pngDavid Anderson2021-11-09 11:25:192022-04-29 10:24:46Peptilogics Strengthens Leadership Team with Three Strategic Appointments
/wp-content/uploads/peptilogics_inline_ko_rgb_72-300x79.png00David Anderson/wp-content/uploads/peptilogics_inline_ko_rgb_72-300x79.pngDavid Anderson2021-11-09 11:20:182022-04-27 13:17:37Peptilogics Strengthens Leadership Team with Five Key Strategic Hires
/wp-content/uploads/peptilogics_inline_ko_rgb_72-300x79.png00David Anderson/wp-content/uploads/peptilogics_inline_ko_rgb_72-300x79.pngDavid Anderson2021-11-09 11:18:332022-04-27 13:15:34Peptilogics and Cerebras Systems Partner on AI Solutions to Advance the Future of Peptide Therapeutics
/wp-content/uploads/peptilogics_inline_ko_rgb_72-300x79.png00David Anderson/wp-content/uploads/peptilogics_inline_ko_rgb_72-300x79.pngDavid Anderson2021-11-09 11:16:222022-04-27 13:13:43Peptilogics to Present First-in-Human Phase 1 Clinical Data of PLG0206 at IDWeek 2021
/wp-content/uploads/peptilogics_inline_ko_rgb_72-300x79.png00David Anderson/wp-content/uploads/peptilogics_inline_ko_rgb_72-300x79.pngDavid Anderson2021-11-09 10:56:042022-04-27 13:10:14Peptilogics Presents Positive First-in-Human Phase 1 Data for its Lead Engineered Antibacterial Peptide, PLG0206, at IDWeek 2021
